NYSEARCA:BBP Virtus LifeSci Biotech Products ETF (BBP) Price, Holdings, & News $65.78 +0.11 (+0.17%) (As of 12/2/2024 ET) Add Compare Share Share Stock Analysis Stock AnalysisChartHoldingsOwnershipRatings About Virtus LifeSci Biotech Products ETF (NYSEARCA:BBP) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get BBP alerts:Sign Up Key Stats Today's Range$65.35▼$65.7950-Day Range$60.53▼$68.4552-Week Range$50.43▼$69.12Volume548 shsAverage Volume1,977 shsMarket Capitalization$23.02 millionAssets Under Management$22.98 millionDividend Yield0.00%Net Expense Ratio0.79%Aggregate RatingModerate Buy ETF OverviewThe Virtus LifeSci Biotech Products ETF (BBP) is an exchange-traded fund that is based on the LifeSci Biotechnology Products index. The fund tracks an index of US-listed biotechnology companies considered to be in the product stage by the index provider. BBP was launched on Dec 17, 2014 and is managed by Virtus.Read More… 5 Stocks Under $5 (Ad)Ready to discover some hidden gems in the stock market? We’ve put together a report of 5 stocks under $5 with huge potential. Whether you’re looking for value or growth, these stocks have the potential to help you make your next winning investment.[Download Your Free Report Here] Virtus LifeSci Biotech Products ETF ExpensesTypeBBPHealth Care ETFsEquity ETFsNYSEARCA ETFsAll ETFsManagement Fee0.79%0.57%0.55%0.51%0.52%Other Expenses0.00%0.30%0.49%0.57%0.53%Total Expense0.79%0.70%0.71%0.73%0.71%Fee Waiver0.00%-0.45%-0.52%-0.67%-0.57%Net Expense0.79%0.61%0.61%0.58%0.59% Receive BBP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Virtus LifeSci Biotech Products ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address BBP ETF News HeadlinesBBP Virtus LifeSci Biotech Products ETFOctober 9, 2024 | seekingalpha.comVirtus LifeSci Biotech Products ETF (BBP)August 25, 2024 | investing.comWhy I'm telling friends to avoid gold stocksBack in November, gold made a tiny move of 1.6%. But according to my backtesting by using a special type of gold trade, I would have seen a 141% gain in just a week. It happened again in March. Gold nudged up 1.2%. This time? A 104% overnight gain. And in June? A 1% gold move turned into a 74% gain in two weeks. Granted, there would have been smaller wins and those that did not work out, but you see, there's a reason I'm telling all my friends to hold off from buying gold or regular gold stocks right now. There's a more lucrative way to play the gold market as we enter a new breakout period. It's all about catching what I call "Acceleration Cycles."December 3, 2024 | DTI (Ad)Virtus LifeSci Biotech Clinical Trials ETF (BBC)August 16, 2024 | investing.comSpinnaker ETF Series (OOSP)April 15, 2024 | finance.yahoo.comAmplify Treatments, Testing and Adv ETFFebruary 29, 2024 | money.usnews.comSee More Headlines BBP ETF - Frequently Asked Questions How have BBP shares performed this year? Virtus LifeSci Biotech Products ETF's stock was trading at $58.09 on January 1st, 2024. Since then, BBP stock has increased by 13.2% and is now trading at $65.7825. View the best growth stocks for 2024 here. Who are Virtus LifeSci Biotech Products ETF's major shareholders? Top institutional shareholders of Virtus LifeSci Biotech Products ETF include Jag Capital Management LLC (1.15%). How do I buy shares of Virtus LifeSci Biotech Products ETF? Shares of BBP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of Virtus LifeSci Biotech Products ETF own? Based on aggregate information from My MarketBeat watchlists, some other companies that Virtus LifeSci Biotech Products ETF investors own include Inovio Pharmaceuticals (INO), Micron Technology (MU), Sanofi (SNY), Gilead Sciences (GILD), Simon Property Group (SPG), Intel (INTC) and Virtus LifeSci Biotech Clinical Trials ETF (BBC). Fund Details IssuerVirtus Fund NameVirtus LifeSci Biotech Products ETF Tax ClassificationRegulated Investment Company Stock ExchangeNYSEARCACurrent SymbolNYSEARCA:BBP Inception Date12/16/2014 Fund ManagerMatthew B. Brown, Seth Kadushin WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkLifeSci Biotechnology Products Index CategorySector FocusHealth Care Development LevelDeveloped Markets RegionNorth America Number of Holdings66 Fund Statistics Assets Under Management$22.98 million Average Daily Volume$1,538.70 Discount/Premium0.01% Administrator, Advisor and Custodian AdministratorVirtus ETF Solutions, LLC AdvisorVirtus ETF Advisers LLC CustodianThe Bank of New York Mellon Corporation DistributorETF Distributors LLC Transfer AgentThe Bank of New York Mellon Corporation TrusteeN/A Lead Market MakerVirtu Financial Options OptionableN/A Short Interest1,500 shs Miscellaneous Outstanding Shares350,004Beta0.89 Creation Unit50,000 Creation Fee$500.00 (Almost) Everything You Need To Know About The EV MarketClick the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise. Get This Free Report Top 10 BBP HoldingsTravere Therapeutics (NASDAQ:TVTX)Holding Weight: 3.69%TG Therapeutics (NASDAQ:TGTX)Holding Weight: 3.00%ADMA Biologics (NASDAQ:ADMA)Holding Weight: 2.87%Alnylam Pharmaceuticals (NASDAQ:ALNY)Holding Weight: 2.38%Mirum Pharmaceuticals (NASDAQ:MIRM)Holding Weight: 2.37%Exelixis (NASDAQ:EXEL)Holding Weight: 2.31%Aurinia Pharmaceuticals (NASDAQ:AUPH)Holding Weight: 2.23%Zai Lab (NASDAQ:ZLAB)Holding Weight: 2.19%Ligand Pharmaceuticals (NASDAQ:LGND)Holding Weight: 2.16%Gilead Sciences (NASDAQ:GILD)Holding Weight: 2.10%Full Holdings DetailsBBP Sector ExposureBBP Industry Exposure This page (NYSEARCA:BBP) was last updated on 12/3/2024 by MarketBeat.com Staff From Our PartnersTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredIs NVDA a sell? Buy this stock instead before Dec 3After months of speculation that Nvidia was "cooling off..." and "running out of steam..." The company is m...Chaikin Analytics | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Virtus LifeSci Biotech Products ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Virtus LifeSci Biotech Products ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
